Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxo-dG), a reliable oxidative stress marker in hypertension

References

• Halliwell B, Gutteridge JMC. Free radicals in biology and medicine3rd ed. Oxford University Press, Oxford, UK 1999
   Google Scholar
• Romero JC, Reckelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 1999; 34: 943–949
   PubMed Web of Science ®Google Scholar
• Griffiths G. Biomarkers. Mol Aspects Med 2002; 23: 101–208
   PubMed Web of Science ®Google Scholar
• Vassalle C, Botto N, Andreassi G, Berti S, Beiagini A. Evidence for enhanced 8-isoprostane plasma levels, as an index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis 2003; 14: 213–218
   PubMed Web of Science ®Google Scholar
• Minuz P, Andrioli G, Degan D, Gaino S, Ortalani R, Tommasolim R, Zuliani V, Lechi A, Lechi C. The F2-isoprostane 8-epiprotanglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol 1998; 18: 1248–1256
   PubMed Web of Science ®Google Scholar
• Chen KC, Achill SS, Kasai DS, Nishimura S, Loeb LA. 8-hydroxyguanine, an abundant form of oxidative DNA damage, causes G–T to A–C susbstitutions. J Biol Chem 1992; 267: 166–172
   Google Scholar
• Gedik CM, Collins A. Establishing the background level of base oxidation in human lymphocyte DNA: Results of an interlaboratory validation study. FASEB J 2005; 19(1)82–84, ESCODD (European standard committee on oxidative DNA damage)
   PubMed Web of Science ®Google Scholar
• Nakabeppu Y, Tsuchimoto D, Ichinoe A, Ohno M, Ide Y, Hirano S, Yoshimura D, Tominaga Y, Furuichi M, Sakumi K. Biological significance of the defense mechanisms against oxidative damage in nucleic acids caused by reactive oxygen species. From mitochondria to nuclei. Ann NY Acad Sci 2004; 1011: 101–111
   Google Scholar
• Cooke MS, Evans MD, Herbert KE, Lunec J. Urinary 8-oxo-2′-deoxyguanosine- source, significance and supplements. Free Radic Res 2000; 32: 381–397
   PubMed Web of Science ®Google Scholar
• Oliva MR, Ripoll F, Muñiz P, Iradi A, Trullenque R, Valls V, Drehmer E, Sáez GT. Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community. Mol Carcinog 1997; 18: 232–243
   PubMed Web of Science ®Google Scholar
• Tormos C, Chaves FJ, García MJ, Garrido F, Jover R, O'Connor JE, Iradi A, Oltra A, Oliva MR, Sáez GT. Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells. Cancer Lett 2004; 208: 103–113
   PubMed Web of Science ®Google Scholar
• Hamilton ML, Guo Z, Fuller CD, Van Remmen H, Ward WF, Austad SN, Troyer DA, Thompson I, Richardson A. A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. Nucleic Acids Res 2001; 29: 2117–2126
   PubMed Web of Science ®Google Scholar
• Topp H, Armbrust S, Lengger C, Schoch G, Davies J, Stichler W, Manz F, Fusch C. Renal excretion of 8-oxo-7,8-dihydro-2′-deoxyguanosine, degradation rates of RNA and metabolic rate in humans. Arch Biochem Biophys 2002; 403: 31–37
   Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560–2572, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee
   PubMed Web of Science ®Google Scholar
• Petrie JC, O'Brien ET, Littler WA, De Swiet M. Recommendations on blood pressure measurement. Br Med J 1986; 293: 611–615, British Hypertension Society
   PubMed Web of Science ®Google Scholar
• Redon J, Miralles A, Liao Y, Lozano JV, Pascual JM, Cooper RS. Circadian variability and microalbuminuria in essential hypertension. J Hypertens 1994; 12: 947–954
   PubMed Web of Science ®Google Scholar
• Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scan J Clin Lab Invest 1968; 21: 77–89
   PubMed Web of Science ®Google Scholar
• Muñiz P, Valls V, Perez-Broseta C, Iradi A, Climent JV, Oliva MR, Sáez GT. The role of 8-hydroxy-2′-deoxyguanosine in rifamycin-induced DNA damage. Free Radic Biol Med 1995; 18: 747–755
   PubMed Web of Science ®Google Scholar
• Asensi MD, Sastre J, Pallardó FV, García de la Asunción J, Estrela JM, Viña J. A high-performance liquid chromatography method for measurement of oxidized glutathione in biological samples. Anal Biochem 1994; 217: 323–328
   PubMed Web of Science ®Google Scholar
• Frenkel K, Zong Z, Wei H, Karkiszka J, Patel U, Rashid K, Georgescu M, Solomon JJ. Quantitative high performance liquid chromatography analysis of DNA oxidized in vitro and in vivo. Anal Biochem 1991; 196: 126–136
   PubMed Web of Science ®Google Scholar
• Latorre A, Moya A, Ayala FJ. Evolution of mitochondrial DNA in Drosophila subobscura. Proc Natl Acad Sci USA 1986; 83: 8649–8653
   PubMed Web of Science ®Google Scholar
• Wei H, Frenkel K. Suppression of tumor promoter-induced oxidative events and DNA damage in vivo by sarcophytol A: A possible mechanism of antipromotion. Cancer Res 1992; 52: 2298–2303
   PubMed Web of Science ®Google Scholar
• Brown RK, McBurney A, Lunec J, Kelly FJ. Oxidative damage to DNA in patients with cystic fibrosis. Free Radic Biol Med 1995; 18: 801–806
   PubMed Web of Science ®Google Scholar
• Raij L. Nitric oxide in hypertension: Relationship with renal injury and left ventricular hypertrophy. Hypertension 1998; 189–193
   Google Scholar
• Nakazono K, Watanabe N, Matsuno K, Sasaki J, Inoue M. Does superoxide underlie the pathogenesis of hypertension?. Proc Natl Acad Sci USA 1991; 88: 10045–10048
   PubMed Web of Science ®Google Scholar
• Wallwork CJ, Parks DA, Schmid-Schonbein GW. Xanthine oxidase activity in the dexametasone-induced hypertensive rat. Microvasc Res 2003; 66(1)30–37
   Web of Science ®Google Scholar
• Cifuentes ME, Pagano PJ. Targeting reactive oxygen species in hypertension. Curr Opin Nephrol Hypertens 2006; 15(2)179–186
   Google Scholar
• Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Saez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003; 41: 1096–1101
   PubMed Web of Science ®Google Scholar
• Blankenberg S, Rupprecht HJ, Bickel Ch, Torzewski M, Hafner G, Tiret L, Smieja M, Cambien F, Meyer J, Lackner KJ. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003; 349: 1605–1613, AtheroGene Investigators
   PubMed Web of Science ®Google Scholar
• Lenton KJ, Therrialut H, Fulop H, Payette H, Wagner JR. Glutathione and ascorbate are negatively correlated with oxidative DNA damage in human lymphocytes. Carcinogenesis 1999; 4: 607–613
   Google Scholar
• Giner V, Tormos C, Chaves FJ, Saez G, Redon J. Microalbuminuria and oxidative stress in essential hypertension. J Intern Med 2004; 255: 588–594
   PubMed Web of Science ®Google Scholar
• Saez GT, Tormos C, Giner V, Chaves FJ, Lozano JV, Iradi A, Redon J. Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress byproducts in human hypertension. Am J Hypertens 2004; 17: 809–816
   PubMed Web of Science ®Google Scholar
• Foksinski M, Gackowski D, Rozalski R, Olinski R. Cellular level of 8-oxo-2′-deoxyguanosine in DNA does not correlate with urinary excretion of the modified base/nucleoside. Acta Biochim Pol 2003; 50: 549–553
   PubMed Web of Science ®Google Scholar
• Lunec J, Holloway KA, Cooke MS, Faux S, Griffiths HR, Evans MD. Urinary 8-oxo2′-deoxyguanosine: Redox regulation of DNA repair in vivo?. Free Radic Biol Med 2002; 33: 875–885
   PubMed Web of Science ®Google Scholar
• Gackowski D, Rozalski R, Roszkowski K, Jawien A, Foksinski M, Olinski R. 8-oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine levels in human urine do not depend on diet. Free Radic Res 2001; 35: 825–832
   PubMed Web of Science ®Google Scholar
• Hayakawa H, Taketomi A, Sakimi K, Kuwano M, Sekiguchi M. Generation and elimination of 8-oxo-7,8-dihydro-2′-deoxyguanosine 5′-triphosphate, a mutagenic substrate for DNA synthesis, in human cells. Biochemistry 1995; 34: 89–95
   PubMed Web of Science ®Google Scholar
• Cooke MS, Evans MD, Dove R, Rozallski R, Gackowski D, Siomek A, Lunec J, Olinski R. DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat Res 2005; 574: 58–66
   PubMed Web of Science ®Google Scholar
• Cooke MS, Evans MD, Burd RM, Patel K, Barmad A, Lunec J, Hutchinson PE. Induction and excretion of ultraviolet-induced 8-oxo-2′-deoxyguanosine and thymine dimmers in vivo: Implications for PUVA. J Invest Dermatol 2001; 116: 281–285
   PubMedGoogle Scholar
• Loft S, Pousen HE, Vistisen K, Knudsen LE. Increased urinary excretion of 8-oxo-2′-deoxyguanosine, a biomarker of oxidative DNA damage, in urban bus drivers. Mutat Res 1999; 441: 11–19
   PubMed Web of Science ®Google Scholar
• Lenger C, Schöch G, Topp H. A high-performance liquid chromatographic method for the determination of 8-oxo-7,8-2′-deoxyguanosine in urine from man and rat. Anal Biochem 2000; 287: 65–72
   Google Scholar
• Weiman A, Belling D, Poulsen H. Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography-electrospray mass spectrometry. Nucleic Acid Res 2002; 30: 4–8
   Google Scholar